Home / Publication / Pharmacokinetics and Safety of Oseltamivir in Patients with End-stage Renal Disease Treated with Automated Peritoneal Dialysis

刊物

Pharmacokinetics and Safety of Oseltamivir in Patients with End-stage Renal Disease Treated with Automated Peritoneal Dialysis

Author(s): Kashyap Patel, Craig Rayner, Mylène Giraudon, Mohamed Kamal, Peter Morcos, Richard Robson, Carl Kirkpatrick

Year: 2015 年 3 月 25 日

Calculating AUC (Linear and Log-linear)

博客

Accumulation: What It Means and How to Calculate It

博客

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

视频

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

视频

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Pharmacokinetics and Safety of Oseltamivir in Patients with End-stage Renal Disease Treated with Automated Peritoneal Dialysis

Pharmacokinetics and Safety of Oseltamivir in Patients with End-stage Renal Disease Treated with Automated Peritoneal Dialysis

Calculating AUC (Linear and Log-linear)

Accumulation: What It Means and How to Calculate It

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

订阅时事通讯

快捷链接

解决方案

联系我们